Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
about
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic reviewRisk factors and biomarkers of life-threatening cancersVitamins and MelanomaMelanoma. Shall we move away from the sun and focus more on embryogenesis, body weight and longevity?Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesisVitamin D, vitamin A, the primary melanoma transcriptome and survivalPre-diagnostic circulating vitamin D and risk of melanoma in menGenome-wide association study identifies three new melanoma susceptibility loci.Vitamin D status and risk for malignant cutaneous melanoma: recent advances.Decreased VDR expression in cutaneous melanomas as marker of tumor progression: new data and analysesVitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR dataThe impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysisAn inherited variant in the gene coding for vitamin D-binding protein and survival from cutaneous melanoma: a BioGenoMEL study.Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy.Malignant melanoma: a pictorial review.IRF4 variants have age-specific effects on nevus count and predispose to melanoma.Vitamin D supplements and cancer incidence and mortality: a meta-analysis.Patterns of expression of DNA repair genes and relapse from melanoma.Vitamin D and cancer.Obesity and cancer: the role of vitamin DSun exposure and melanoma survival: a GEM studyDietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation.Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D).Role of vitamin d in the prevention of pancreatic cancer.Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.Low serum 25-hydroxyvitamin d concentrations are associated with increased risk for melanoma and unfavourable prognosis.Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate.From the bench to emerging new clinical concepts: Our present understanding of the importance of the vitamin D endocrine system (VDES) for skin cancerVitamin D insufficiency and prognosis in chronic lymphocytic leukemiaThe clinicopathological and gene expression patterns associated with ulceration of primary melanomaExpression of vitamin D receptor decreases during progression of pigmented skin lesions.Vitamin D and skin cancer.Inverse association between dietary vitamin D and risk of cutaneous melanoma in a northern Italy population.Sunny holidays before and after melanoma diagnosis are respectively associated with lower Breslow thickness and lower relapse rates in ItalyVitamin D receptor polymorphisms in patients with cutaneous melanomaCalcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial.The determinants of serum vitamin D levels in participants in a melanoma case-control study living in a temperate climate.25-Hydroxyvitamin D2 /D3 levels and factors associated with systemic inflammation and melanoma survival in the Leeds Melanoma Cohort.Vitamin D receptor (VDR) polymorphisms and skin cancer: A systematic review.
P2860
Q22305894-0AC7B214-4D77-4815-8FBC-6BA24555E4C4Q26774591-400D41BC-B724-4C2B-8FFD-714EAFFF542FQ26799314-CEB4B705-B82A-448B-BEB1-924084DDE680Q26853315-485E4F6E-6FA0-4072-BD1E-B7152BB406EBQ26859617-44DB7995-5D15-4435-8D7E-41C1B79C2E33Q28078120-6189AA26-8EF8-4DA5-98ED-10C4D8928B68Q28730259-CDE5984C-3525-420E-9207-DD75963F5C2CQ29416994-E46815E5-FA76-4159-9639-8916F9E4E680Q30490787-0EEC83B0-2C30-4E56-80CA-7CC62266C2C0Q30830686-91972EF7-319B-4AE8-9C22-B27DC7558C5FQ33483893-C20103BC-C9BB-4D43-994A-8C04C02AA8DEQ33577607-450E9162-1C55-42D2-8E5B-A05DE913B2AEQ33785471-0FD10B2B-5A73-42A5-9863-0B074B1642D6Q33917630-8B0A1A4B-0BED-43BA-B818-BE7462A2DC6CQ33960191-36F9FE2D-9B9B-49A9-A48E-65989099AAF4Q33960494-A8E45529-490D-4C04-91C3-E754F4AD2A13Q34113467-E37FAC4B-A2E5-4061-BB60-FB5CC79E0217Q34273603-DA5B4488-B3EF-4568-9F74-83222FAB62ADQ34278228-239E35F7-DBC3-4090-A42B-9F048FC20E89Q34278744-89BA4080-1CB3-4C45-92F6-37557BD18F4FQ34287821-FE469291-3CEC-44DB-871F-4B2822DD398FQ34345056-D8E93505-183B-4C9C-9767-E501AB72B307Q34383359-B7724FF3-4D89-42D4-B947-22C5898AF70AQ34460037-EE5A9714-4FC0-4424-81CB-90628857B658Q34512748-0D937AC6-E273-4384-98F7-4E81F12E0F13Q34588331-1D5D611B-AB2F-4128-B615-DCF3746B1ABAQ34599395-D940DFB8-D542-401A-9FE1-4EEB059E3EC3Q34615791-1B256BCE-357D-460C-A208-231ECF4FFF5EQ34637963-EFD8CA2E-2E70-4788-8832-BB79FEC90067Q34667541-FBF03570-2F4B-4C48-BE4A-5946F21476FAQ34772146-DFF02AB6-2590-40DB-A520-5EF256B3EA8AQ34803691-3F199903-C09C-4B68-B457-47242DF48349Q34964807-E94B811D-958F-4C3E-AC7C-D81EC0A85F46Q34995493-809221D0-22C5-43B1-88B3-6C6E5148FAFAQ35041046-2094BF84-4D44-45EB-B153-6616A5FBD617Q35103696-DFF91340-3146-467A-B089-00277A83E218Q35170221-54CB8070-0A9D-468C-9ADE-6BE6C99116BFQ35222359-AA11F543-8360-4F77-8486-ED8A94A5A556Q35417462-3E8E1955-C116-41F8-A4CA-5849B7B96C2AQ35558890-53161416-1A44-4282-9F02-7B3FD3C80F88
P2860
Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@en
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@en-gb
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@nl
type
label
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@en
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@en-gb
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@nl
prefLabel
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@en
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@en-gb
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@nl
P2093
P2860
P50
P356
P1476
Serum 25-hydroxyvitamin D3 lev ...... on and survival from melanoma.
@en
P2093
Birute Karpavicius
Chandra Bertram
Clarissa Nolan
David E Elder
Edwina Gerry
Faye Elliott
Jerry Marsden
Julia A Newton-Bishop
Juliette Randerson-Moor
Kairen Kukalizch
P2860
P304
P356
10.1200/JCO.2009.22.1135
P407
P577
2009-09-21T00:00:00Z